Product Center
Received national level praise!
- Categories:Company news
- Author:
- Origin:
- Time of issue:2024-03-01
- Views:
(Summary description)Recently, recommended by the provincial adverse drug reaction monitoring institutions and comprehensively evaluated by the National Adverse Drug Reaction Monitoring Center, Ab&B Bio-Tech CO., LTD. JS has outstanding performance in fulfilling its main responsibilities in the monitoring of adverse drug reactions in 2023 and has been praised by the National Adverse Reaction Monitoring Center.
Received national level praise!
(Summary description)Recently, recommended by the provincial adverse drug reaction monitoring institutions and comprehensively evaluated by the National Adverse Drug Reaction Monitoring Center, Ab&B Bio-Tech CO., LTD. JS has outstanding performance in fulfilling its main responsibilities in the monitoring of adverse drug reactions in 2023 and has been praised by the National Adverse Reaction Monitoring Center.
- Categories:Company news
- Author:
- Origin:
- Time of issue:2024-03-01 16:18
- Views:
Recently, recommended by the provincial adverse drug reaction monitoring institutions and comprehensively evaluated by the National Adverse Drug Reaction Monitoring Center, Ab&B Bio-Tech CO., LTD. JS has outstanding performance in fulfilling its main responsibilities in the monitoring of adverse drug reactions in 2023 and has been praised by the National Adverse Reaction Monitoring Center.
The achievement of the results fully reflects the affirmation of the preliminary work of Ab&B Bio-Tech CO.,LTD.JS by adverse drug reaction monitoring institutions at all levels, and Ab&B Bio-Tech CO.,LTD.JS will cherish the honor, continue to implement the "four strictest" requirements and the spirit of General Secretary Xi Jinping's series of important instructions on drug safety work, and perform their duties with a stronger sense of responsibility and mission, improve their pharmacovigilance ability, and contribute to the protection of public health!
Relevant information
-
Further advances in orthopoxvirus mRNA vaccinesFrom April 2 to April 4, 2024, Dr. Xiong Nolin, Deputy General Manager of EW BioTech (Shanghai) Co., Ltd (hereinafter referred to as EW Bio), a wholly-owned subsidiary of Jiangsu Zhonghui Yuantong Bio-Technology Co., Ltd (hereinafter referred to as EW Bio), was invited to participate in the World Vaccine Congress 2024, where he made a keynote speech and exchanged the results of the company's important R & D project of the Orthopoxvirus mRNA vaccine, which was received by the international counterparts with great interest and recognition. - Huierkangxin has been selected for the 2024 Jiangsu Province Innovative Pharmaceutical Equipment Special Award List! 03-08
- Received national level praise! 03-01
- Recombinant herpes zoster vaccine (CHO cell) IND application accepted 02-23
- Ab&B Bio Tech CO., LTD. JS invited to attend the China Ukraine Trade Cooperation Seminar 11-28
Have a project？Get a touch!
Caring for life, protecting health, and making global technological innovation vaccines are the mission of Ab&B Bio
Contact
E-mail:info@abbbio.com.cn
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us
